Form 4: IRIDEX CEO Patrick Mercer Disposes Shares

Iridex Corporation CEO Patrick Mercer disposed of 3,990 shares of common stock to cover tax obligations.

Summary

• Patrick Mercer, President and CEO of Iridex Corporation, disposed of 3,990 shares of common stock.
• The transaction occurred on June 13, 2026, at a price of $1.12 per share.
• The disposal was executed to satisfy tax withholding obligations related to the vesting of equity awards.
• Following this transaction, Patrick Mercer retains beneficial ownership of 368,784 shares of Iridex common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the transaction was a mandatory tax-related disposal rather than a market-driven sale.

Positives

• The transaction was a routine administrative action related to tax withholding rather than a discretionary sale.

Negatives

• The disposal reduces the CEO's direct equity stake in the company.

Risks

• Continued reliance on equity-based compensation may lead to further periodic share disposals by management.

Future Outlook

No forward-looking guidance or strategic outlook was provided in this filing.

Industry Context

StockSavvy.ai notes that routine share disposals for tax withholding are standard practice for corporate executives and generally do not signal a change in management's outlook on the company's performance.

Comparison to Industry Standards

• The transaction is consistent with standard executive compensation and tax compliance practices across the medical device industry.

Stakeholder Impact

• Minimal impact on shareholders as the transaction was a routine tax-related disposal.

Key Dates

Keywords

IRIX, Iridex, Insider Trading, Form 4, CEO, Equity Compensation